Recall Issued on Multiple Adult-Use Cannabis Products Tested by Keystone
A keystone laboratory cannabis recall has been issued for multiple adult-use products in New York. This recall addresses potential contamination and safety risks in regulated cannabis markets. Consumers should verify product safety with dispensaries to…
OCM Issues Precautionary Recall for Keystone Lab Cannabis Products
The New York Office of Cannabis Management issued a precautionary cannabis recall for select products tested by Keystone Lab. This recall highlights concerns about cannabis product safety and testing accuracy. Patients should verify their products…
Does Cannabis Cause Judgment Impairment and Increase Manipulation Risk?
Cannabis judgment impairment is a critical concern for patients using THC. High doses of THC can disrupt executive function and increase vulnerability to social influence. Understanding cannabis judgment impairment helps patients make safer choices.
Modulating the Endocannabinoid System in Alcohol Use Disorder: A Translational Systematic Review
ECS modulation alcohol use disorder offers a novel approach targeting neurobiological mechanisms of craving and relapse. This translational review highlights cannabinoid receptor roles in alcohol dependence. ECS-targeted therapies may expand options for…
Many NC Candidates Support Medical Marijuana Legalization | Raleigh News & Observer
The North Carolina medical cannabis program is gaining political momentum as candidates across parties voice support. This program could provide legal access to cannabis therapies for patients with chronic pain, cancer, and epilepsy. Regulated access…
Investigation Finds Hemp Products Contain Illegal THC and Contaminants
Hemp product contamination risks pose serious health concerns due to illegal THC levels and harmful substances like mold and pesticides. Patients may unknowingly consume unsafe hemp products lacking proper regulation. Clinicians should counsel patients…
DPH Commissioner on Measles Outbreaks and Cannabis Potency
Cannabis potency restrictions could affect patient access to high-concentration products needed for therapeutic efficacy. State health authorities consider new labeling and potency regulations. Clinicians must prepare for dosing adjustments amid evolving…
The Week in Weed: February 27, 2026 – Lexology Insights
Acute cannabis effects include perceptual, cardiovascular, and cognitive changes that are time-limited but clinically important. Understanding these effects helps clinicians counsel patients effectively during therapy initiation. This knowledge supports…
Ghana Launches Regulated Medicinal Cannabis Programme
Ghana medicinal cannabis programme marks a significant regulatory milestone in West Africa. This programme enables generation of population-specific clinical data for cannabis therapeutics. It strengthens the global evidence base through structured…
The Role of the Endocannabinoid System in Placebo Analgesia
The endocannabinoid system placebo analgesia plays a key role in mediating pain relief by combining expectation and cannabinoid signaling. This mechanism suggests that both pharmacological and psychological factors contribute to analgesia. Understanding…